Literature DB >> 26314780

Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

M Ducreux1, A Sa Cuhna2, C Caramella3, A Hollebecque4, P Burtin5, D Goéré6, T Seufferlein7, K Haustermans8, J L Van Laethem9, T Conroy10, D Arnold11.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26314780     DOI: 10.1093/annonc/mdv295

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  302 in total

Review 1.  Adjuvant treatment for pancreatic ductal carcinoma.

Authors:  T Macarulla; T Fernández; M E Gallardo; O Hernando; A M López; M Hidalgo
Journal:  Clin Transl Oncol       Date:  2017-06-21       Impact factor: 3.405

Review 2.  Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma.

Authors:  Yvette N Lamb; Lesley J Scott
Journal:  Drugs       Date:  2017-05       Impact factor: 9.546

3.  Three-Dimensional Fixation: Pathological Protocol Following Pancreaticoduodenectomy with Portal Vein Resection for Pancreatic Cancer.

Authors:  Masayuki Tanaka; Yosuke Inoue; Kiyoshi Matsueda; Makiko Hiratsuka; Mariko Muto; Shoji Kawakatsu; Yoshihiro Ono; Yoshihiro Mise; Takeaki Ishizawa; Hiromichi Ito; Yu Takahashi; Yutaka Takazawa; Akio Saiura
Journal:  J Gastrointest Surg       Date:  2019-04-01       Impact factor: 3.452

Review 4.  Biomarkers in pancreatic ductal adenocarcinoma.

Authors:  J Gallego; C López; R Pazo-Cid; F López-Ríos; A Carrato
Journal:  Clin Transl Oncol       Date:  2017-06-14       Impact factor: 3.405

5.  A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study.

Authors:  Taiga Otsuka; Tsuyoshi Shirakawa; Mototsugu Shimokawa; Futa Koga; Yasunori Kawaguchi; Yujiro Ueda; Junichi Nakazawa; Azusa Komori; Satoshi Otsu; Shiho Arima; Masaru Fukahori; Yoshinobu Okabe; Akitaka Makiyama; Hiroki Taguchi; Takuya Honda; Taro Shibuki; Kenta Nio; Yasushi Ide; Toshihiko Mizuta; Kenji Mitsugi; Norio Ureshino
Journal:  Int J Clin Oncol       Date:  2021-01-23       Impact factor: 3.402

Review 6.  Systematic appraisal of guidelines for the diagnosis of pancreatic cancer.

Authors:  Xin-Jie Liu; Ting Yang; Xin Shi; Bing-He Xiao; Li-Ya An; Su-Yun Zheng; Yu-Xing Qi; Da-Li Sun
Journal:  Gland Surg       Date:  2021-04

7.  Efficacy of endoscopic self-expandable metal stent placement versus surgical bypass for inoperable pancreatic cancer-related malignant biliary obstruction: a propensity score-matched analysis.

Authors:  Ka Wing Ma; Albert Chi Yan Chan; Wong Hoi She; Kenneth Siu Ho Chok; Wing Chiu Dai; Simon Tsang; Tan To Cheung; Chung Mau Lo
Journal:  Surg Endosc       Date:  2017-08-04       Impact factor: 4.584

Review 8.  Exosomal biomarkers for cancer diagnosis and patient monitoring.

Authors:  Amy Makler; Waseem Asghar
Journal:  Expert Rev Mol Diagn       Date:  2020-02-20       Impact factor: 5.225

9.  FOLFIRINOX in patients with peritoneal carcinomatosis from pancreatic adenocarcinoma: a retrospective study.

Authors:  E Bonnet; C Mastier; A Lardy-Cléaud; P Rochefort; M Sarabi; P Guibert; A Cattey-Javouhey; F Desseigne; C de La Fouchardière
Journal:  Curr Oncol       Date:  2019-08-01       Impact factor: 3.677

Review 10.  Pancreatic cancer: Are "liquid biopsies" ready for prime-time?

Authors:  Alexandra R Lewis; Juan W Valle; Mairead G McNamara
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.